These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 9528862

  • 1. Inhibition of a naturally occurring EGFR oncoprotein by the p185neu ectodomain: implications for subdomain contributions to receptor assembly.
    O'Rourke DM, Nute EJ, Davis JG, Wu C, Lee A, Murali R, Zhang HT, Qian X, Kao CC, Greene MI.
    Oncogene; 1998 Mar 05; 16(9):1197-207. PubMed ID: 9528862
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of p185neu kinase activity and cellular transformation by co-expression of a truncated neu protein.
    Qian X, O'Rourke DM, Zhao H, Greene MI.
    Oncogene; 1996 Nov 21; 13(10):2149-57. PubMed ID: 8950982
    [Abstract] [Full Text] [Related]

  • 3. The role of distinct p185neu extracellular subdomains for dimerization with the epidermal growth factor (EGF) receptor and EGF-mediated signaling.
    Kumagai T, Davis JG, Horie T, O'Rourke DM, Greene MI.
    Proc Natl Acad Sci U S A; 2001 May 08; 98(10):5526-31. PubMed ID: 11320205
    [Abstract] [Full Text] [Related]

  • 4. A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis.
    Nagane M, Coufal F, Lin H, Bögler O, Cavenee WK, Huang HJ.
    Cancer Res; 1996 Nov 01; 56(21):5079-86. PubMed ID: 8895767
    [Abstract] [Full Text] [Related]

  • 5. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
    Tang CK, Gong XQ, Moscatello DK, Wong AJ, Lippman ME.
    Cancer Res; 2000 Jun 01; 60(11):3081-7. PubMed ID: 10850460
    [Abstract] [Full Text] [Related]

  • 6. Absence of autophosphorylation site Y882 in the p185neu oncogene product correlates with a reduction of transforming potential.
    Zhang HT, O'Rourke DM, Zhao H, Murali R, Mikami Y, Davis JG, Greene MI, Qian X.
    Oncogene; 1998 Jun 04; 16(22):2835-42. PubMed ID: 9671404
    [Abstract] [Full Text] [Related]

  • 7. Transcriptional regulation of signal regulatory protein alpha1 inhibitory receptors by epidermal growth factor receptor signaling.
    Kapoor GS, Kapitonov D, O'Rourke DM.
    Cancer Res; 2004 Sep 15; 64(18):6444-52. PubMed ID: 15374953
    [Abstract] [Full Text] [Related]

  • 8. Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor.
    Mishima K, Johns TG, Luwor RB, Scott AM, Stockert E, Jungbluth AA, Ji XD, Suvarna P, Voland JR, Old LJ, Huang HJ, Cavenee WK.
    Cancer Res; 2001 Jul 15; 61(14):5349-54. PubMed ID: 11454673
    [Abstract] [Full Text] [Related]

  • 9. Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3'-kinase and distinct from that induced by hypoxia.
    Maity A, Pore N, Lee J, Solomon D, O'Rourke DM.
    Cancer Res; 2000 Oct 15; 60(20):5879-86. PubMed ID: 11059786
    [Abstract] [Full Text] [Related]

  • 10. Coregulation of epidermal growth factor receptor/human epidermal growth factor receptor 2 (HER2) levels and locations: quantitative analysis of HER2 overexpression effects.
    Hendriks BS, Opresko LK, Wiley HS, Lauffenburger D.
    Cancer Res; 2003 Mar 01; 63(5):1130-7. PubMed ID: 12615732
    [Abstract] [Full Text] [Related]

  • 11. Immunotoxins that target an oncogenic mutant epidermal growth factor receptor expressed in human tumors.
    Lorimer IA, Wikstrand CJ, Batra SK, Bigner DD, Pastan I.
    Clin Cancer Res; 1995 Aug 01; 1(8):859-64. PubMed ID: 9816055
    [Abstract] [Full Text] [Related]

  • 12. Herstatin, an autoinhibitor of the epidermal growth factor receptor family, blocks the intracranial growth of glioblastoma.
    Staverosky JA, Muldoon LL, Guo S, Evans AJ, Neuwelt EA, Clinton GM.
    Clin Cancer Res; 2005 Jan 01; 11(1):335-40. PubMed ID: 15671564
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal-regulatory proteins (SIRPs).
    Wu CJ, Chen Z, Ullrich A, Greene MI, O'Rourke DM.
    Oncogene; 2000 Aug 17; 19(35):3999-4010. PubMed ID: 10962556
    [Abstract] [Full Text] [Related]

  • 14. Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling.
    Chakravarti A, Loeffler JS, Dyson NJ.
    Cancer Res; 2002 Jan 01; 62(1):200-7. PubMed ID: 11782378
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of the type III epidermal growth factor receptor variant mutant receptor by dominant-negative EGFR-CD533 enhances malignant glioma cell radiosensitivity.
    Lammering G, Hewit TH, Holmes M, Valerie K, Hawkins W, Lin PS, Mikkelsen RB, Schmidt-Ullrich RK.
    Clin Cancer Res; 2004 Oct 01; 10(19):6732-43. PubMed ID: 15475464
    [Abstract] [Full Text] [Related]

  • 16. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y, Li X, Jiang J, Frank SJ.
    Oncogene; 2006 Dec 07; 25(58):7565-76. PubMed ID: 16785991
    [Abstract] [Full Text] [Related]

  • 17. A soluble ectodomain of LRIG1 inhibits cancer cell growth by attenuating basal and ligand-dependent EGFR activity.
    Goldoni S, Iozzo RA, Kay P, Campbell S, McQuillan A, Agnew C, Zhu JX, Keene DR, Reed CC, Iozzo RV.
    Oncogene; 2007 Jan 18; 26(3):368-81. PubMed ID: 16847455
    [Abstract] [Full Text] [Related]

  • 18. Oncogenic activation of the PDGF beta receptor by the transmembrane domain of p185neu*.
    Petti LM, Irusta PM, DiMaio D.
    Oncogene; 1998 Feb 19; 16(7):843-51. PubMed ID: 9484775
    [Abstract] [Full Text] [Related]

  • 19. ErbB receptor tyrosine kinase network inhibition radiosensitizes carcinoma cells.
    Contessa JN, Abell A, Valerie K, Lin PS, Schmidt-Ullrich RK.
    Int J Radiat Oncol Biol Phys; 2006 Jul 01; 65(3):851-8. PubMed ID: 16751066
    [Abstract] [Full Text] [Related]

  • 20. Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression.
    Micallef J, Taccone M, Mukherjee J, Croul S, Busby J, Moran MF, Guha A.
    Cancer Res; 2009 Oct 01; 69(19):7548-56. PubMed ID: 19773446
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.